These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28155308)

  • 1. Ototoxicity management: An investigation into doctors' knowledge and practices, and the roles of audiologists in a tertiary hospital.
    Wium A; Gerber B
    S Afr J Commun Disord; 2016 Dec; 63(1):e1-e15. PubMed ID: 28155308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Are the Current Audiological Practices for Ototoxicity Assessment and Management in the South African Healthcare Context?
    Khoza-Shangase K; Masondo N
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32290287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives and practices of ototoxicity monitoring.
    Paken J; Govender CD; Pillay M; Sewram V
    S Afr J Commun Disord; 2020 May; 67(1):e1-e10. PubMed ID: 32501032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ototoxicity: A review of South African studies.
    Moodley S; Storbeck C; Gama N
    S Afr Fam Pract (2004); 2021 Mar; 63(1):e1-e10. PubMed ID: 33764142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public awareness of audiology, hearing and hearing health in the Limpopo Province, South Africa.
    Joubert K; Sebothoma B; Kgare KS
    S Afr J Commun Disord; 2017 Sep; 64(1):e1-e9. PubMed ID: 29041791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of adult patients with tinnitus: Preparedness, perspectives and practices of audiologists.
    Dawood F; Khan NB; Bagwandin V
    S Afr J Commun Disord; 2019 Nov; 66(1):e1-e10. PubMed ID: 31793315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Audiologists' perceived value of ototoxicity management and barriers to implementation for at-risk cancer patients in VA: the OtoMIC survey.
    Konrad-Martin D; Polaski R; DeBacker JR; Theodoroff SM; Garinis A; Lacey C; Johansson K; Mannino R; Milnes T; Hungerford M; Clark KD
    J Cancer Surviv; 2023 Feb; 17(1):69-81. PubMed ID: 36729345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed consent--a survey of doctors' practices in South Africa.
    Henley L; Benatar SR; Robertson BA; Ensink K
    S Afr Med J; 1995 Dec; 85(12):1273-8. PubMed ID: 8600583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of final year medicine, pharmacy, audiology and nursing students in South Africa on drug-induced ototoxicity: A pilot study.
    Mogole O; Schellack N; Hollander C; Ramma L
    S Afr J Commun Disord; 2019 Nov; 66(1):e1-e12. PubMed ID: 31793316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Pursuit of Preventive Audiology in South Africa: Scoping the Context for Ototoxicity Assessment and Management.
    Khoza-Shangase K; Masondo N
    J Pharm Bioallied Sci; 2021; 13(1):46-60. PubMed ID: 34084048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology.
    Garinis AC; Cornell A; Allada G; Fennelly KP; Maggiore RJ; Konrad-Martin D
    Int J Audiol; 2018 Sep; 57(sup4):S19-S24. PubMed ID: 28978238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The practices, challenges and recommendations of South African audiologists regarding managing children with auditory processing disorders.
    Fouché-Copley C; Govender S; Khan N
    S Afr J Commun Disord; 2016 Jun; 63(1):. PubMed ID: 27380913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of occupational noise induced hearing loss in the mining sector in South Africa: Where are the audiologists?
    Moroe N; Khoza-Shangase K
    J Occup Health; 2018 Sep; 60(5):376-382. PubMed ID: 29984739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current state of ototoxicity monitoring in New Zealand.
    Steffens L; Venter K; O'Beirne GA; Kelly-Campbell R; Gibbs D; Bird P
    N Z Med J; 2014 Jul; 127(1398):84-97. PubMed ID: 25146864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program.
    Paken J; Govender CD; Sewram V
    BMC Womens Health; 2017 Dec; 17(1):129. PubMed ID: 29228931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "What's Going on With My Ears?": Some Reflections on Managing Uncertainty in the Audiology Consultation.
    Watermeyer J; Kanji A; Brom L
    Am J Audiol; 2020 Sep; 29(3):504-512. PubMed ID: 32569482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin-associated ototoxicity: perspectives from a single institution cervical cancer cohort and implications for developing a locally responsive monitoring programme in a public healthcare setting.
    Paken J; Govender CD; Pillay M; Sewram V
    BMC Health Serv Res; 2022 Jun; 22(1):791. PubMed ID: 35717191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity.
    Paken J; Govender CD; Pillay M; Ayele BT; Sewram V
    BMC Womens Health; 2021 Apr; 21(1):164. PubMed ID: 33879158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ototoxic and nephrotoxic drugs in neonatal intensive care units: results of a Spanish and Italian survey.
    Arribas C; Decembrino N; Raffaeli G; Amodeo I; González-Caballero JL; Riaza M; Ortiz-Movilla R; Massenzi L; Gizzi C; Araimo G; Cattarelli D; Aversa S; Martinelli S; Frezza S; Orfeo L; Mosca F; Cavallaro G; Garrido F;
    Eur J Pediatr; 2024 Jun; 183(6):2625-2636. PubMed ID: 38492032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reasons for under-reporting of notifiable conditions.
    Abdool Karim SS; Dilraj A
    S Afr Med J; 1996 Jul; 86(7):834-6. PubMed ID: 8764911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.